Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.60
01.12.21
-
01.12.22
-4.30%
12.12.21

buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€1.43
01.12.21
-
01.12.22
20.66%
12.12.21

Risky Investment
buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€5.88
01.12.21
-
01.12.22
-61.58%
02.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€14.52
01.12.21
-
01.12.22
-11.23%
11.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.91
01.12.21
-
01.12.22
-1.46%
11.12.21

buy
Invitae Corp

Start price
Target price
Perf. (%)
€15.29
01.12.21
€20.00
31.12.23
-90.75%
08.05.23

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€66.00
01.12.21
€50.00
31.12.23
16.67%
08.05.23

Could be very worthwhile Investment >20% year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
VBI Vaccines Inc.

Start price
Target price
Perf. (%)
€85.80
01.12.21
-
01.12.22
-26.15%
11.12.21

buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€23.38
30.11.21
€25.00
30.11.22
-71.89%
07.07.22

Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
Valneva SE

Start price
Target price
Perf. (%)
€27.10
30.11.21
€36.00
30.11.22
-34.61%
08.01.22

buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-50.67%
10.08.22

Could be worthwhile Investment >10% per year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-74.99%
01.12.22

Cellectis Nom.

Start price
Target price
Perf. (%)
€7.61
30.11.21
-
30.11.22
1.58%
12.12.21

buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.44
30.11.21
-
30.11.22
-3.29%
12.12.21

buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.21
30.11.21
-
30.11.22
0.48%
12.12.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€2.23
29.11.21
-
29.11.22
-22.74%
11.12.21

buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€49.00
29.11.21
-
29.11.22
29.80%
30.11.22

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€41.50
29.11.21
-
29.11.25
-56.01%
21.03.23

Could be very worthwhile Investment >20% year
Krystal Biotech

Start price
Target price
Perf. (%)
€77.00
29.11.21
-
29.11.22
-19.48%
10.12.21

Probably not worthwhile Investment